Received: 17 November 2017
Accepted: 19 February 2018
First Online: 27 February 2018
Ethics approval and consent to participate
: The study protocol was approved by the Hamilton Integrated Research Ethics Board, St. Joseph’s Healthcare (Hamilton, Ontario, Canada). We have written consent from all patients from whom tissue samples were procured with respect to the protocols that were performed in the laboratory research, and dissemination of the results in the form of a journal article.
: Copies of signed consent form can be made available if requested/required.
: PN is supported by the Canada Research Chair program. He has received consultancy fees from AstraZeneca, Boehringer Ingelheim, Sanofi, Teva, and Roche; research support from GlaxoSmithKline, AstraZeneca, and Novartis; and lecture fees from Roche, AstraZeneca, and Novartis. AG is supported by NSERC Masters studentship. Rest of the contributing authors do not have any conflict of interest to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.